Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

Autor: Janssen JJWM; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, loc. VUmc, Amsterdam, The Netherlands. j.janssen@amsterdamumc.nl., Löwenberg B; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Manz M; USZ Zürich, Zürich, Switzerland.; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands., Biemond BJ; Department of Hematology, Amsterdam University Medical Centers, loc. AMC, Amsterdam, The Netherlands., Westerweel PE; Albert Schweitzer Hospital, Dordrecht, The Netherlands., Klein SK; Department of Hematology, University Medical Center, Groningen, The Netherlands., Fehr M; Kantonsspital St. Gallen, St. Gallen, Switzerland., Sinnige HAM; Jeroen Bosch Hospital, Den Bosch, The Netherlands., Efthymiou A; HFR, Fribourg, Switzerland., Legdeur MCJC; Medisch Spectrum Twente, Enschede, The Netherlands., Pabst T; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.; Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland., Gregor M; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.; KSL, Luzern, Switzerland., van der Poel MWM; Dept. of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Deeren D; AZ Delta, Roeselare, Belgium., Tick LW; Maxima Medical Center, Eindhoven, The Netherlands., Jongen-Lavrencic M; Department of Hematology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Obbergh F; Hospital Saint Paul Jolimont, Haine, Belgium., Boersma RS; Amphia Hospital, Breda, The Netherlands., de Weerdt O; Antonius Hospital, Nieuwegein, The Netherlands., Chalandon Y; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.; Division of Hematology, Department of Oncology, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland., Heim D; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.; University Hospital, Basel, Switzerland., Spertini O; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.; Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland., van Sluis G; Isala Clinics, Zwolle, The Netherlands., Graux C; Mont Godinne, Yvoir, Belgium., Stüssi G; SAKK Swiss Clinical Cancer Research Group, Amsterdam, The Netherlands.; IOSI, Belinzona, Switzerland., van Norden Y; Hovon Data Center, Erasmus Medical Center, Rotterdam, The Netherlands., Ossenkoppele GJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, loc. VUmc, Amsterdam, The Netherlands.

Publikováno v: Leukemia [Leukemia] 2022 Sep; Vol. 36 (9), pp. 2189-2195. Date of Electronic Publication: 2022 Jul 22.

Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland.

Autor: Moccia AA; Medical Oncology Clinic, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Aeppli S; Medical Oncology and Hematology Clinic, Kantonsspital St. Gallen, St. Gallen, Switzerland., Güsewell S; Clinical Trials Unit, Kantonsspital St. Gallen, St. Gallen, Switzerland., Bargetzi M; Hematology, Kantonsspital Aarau, Aarau, Switzerland., Caspar C; Medical Oncology and Hematology, Kantonsspital Baden, Baden, Switzerland., Brülisauer D; Medical Oncology Clinic, Inselspital, University Hospital of Bern, Bern, Switzerland., Ebnöther M; Medical Oncology and Hematology, Claraspital, Basel, Switzerland., Fehr M; Medical Oncology and Hematology Clinic, Kantonsspital St. Gallen, St. Gallen, Switzerland., Fischer N; Medical Oncology and Hematology Clinic, Kantonsspital Winterthur, Winterthur, Switzerland., Ghilardi G; Hematology Clinic, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Krasniqi F; Medical Oncology Clinic, University Hospital of Basel, Basel, Switzerland., Lang N; Medical Oncology Clinic, University Hospital of Geneva, Genève, Switzerland., Mey U; Medical Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland., Mingrone W; Medical Oncology Clinic, Kantonsspital Olten, Olten, Switzerland., Novak U; Medical Oncology Clinic, Inselspital, University Hospital of Bern, Bern, Switzerland., Pfleger C; Medical Oncology and Hematology, Claraspital, Basel, Switzerland., Richter P; Medical Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland., Rütti M; Internal Medicine Clinic, Spital Wil, Wil, Switzerland., Schmidt A; Medical Oncology and Hematology Clinic, Stadtspital Triemli, Zürich, Switzerland., Stenner F; Medical Oncology Clinic, University Hospital of Basel, Basel, Switzerland., Voegeli M; Medical Oncology and Hematology Clinic, Kantonsspital Baselland, Liestal, Switzerland., Zander T; Medical Oncology, Luzerner Kantonsspital, Luzern, Switzerland., Zucca E; Medical Oncology Clinic, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Hitz F; Medical Oncology and Hematology Clinic, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Publikováno v: Hematological oncology [Hematol Oncol] 2021 Apr; Vol. 39 (2), pp. 196-204. Date of Electronic Publication: 2020 Dec 23.

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

Autor: Ossenkoppele GJ; Amsterdam University Medical Cente, location VUMC, Amsterdam, Netherlands. g.ossenkoppele@amsterdamumc.nl., Breems DA; Netwerk Antwerpen, Antwerp, Belgium., Stuessi G; Bellinzona-IOSI, Bellinzona, Switzerland., van Norden Y; HOVON Data Center, Erasmus MC- Department of Hematology, Rotterdam, The Netherlands., Bargetzi M; Aarau- Kantonsspital, Aarau, Switzerland., Biemond BJ; Amsterdam University Medical Center, location AMC, Amsterdam, Netherlands., A von dem Borne P; Leiden University Medical Center, Leiden, Netherlands., Chalandon Y; University Hospital and University of Geneva, Genève, Switzerland., Cloos J; Amsterdam University Medical Cente, location VUMC, Amsterdam, Netherlands., Deeren D; Roeselare-AZ Delta, Roeselare, Belgium., Fehr M; St Gallen-Kantonnsspital, St. Gallen, Switzerland., Gjertsen B; Haukeland University Hospital, Bergen (N), Norway., Graux C; Yvoir-MontGodinne, Yvoir, Belgium., Huls G; University Medical Center, Groningen, Netherlands., Janssen JJJW; Amsterdam University Medical Cente, location VUMC, Amsterdam, Netherlands., Jaspers A; Hôpital Citadelle, Liège (B), Belgium., Jongen-Lavrencic M; Erasmus University Medical Center, Rotterdam, Netherlands., de Jongh E; Dordrecht ASZ, Dordrecht, Netherlands., Klein SK; Meander Medical Center, Amersfoort, Netherlands., van der Klift M; Amphia-Breda, Breda, Netherlands., van Marwijk Kooy M; Isala Hospital, Zwolle, Netherlands., Maertens J; Hospital Gasthuisberg, Leuven (B), Belgium., Michaux L; Center for Human Genetics, KU Leuven and University Hospitals Leuven, Leuven, Belgium., van der Poel MWM; Maastricht University Medical Center, Maastricht, Netherlands., van Rhenen A; UMC Utrecht, Utrecht, Netherlands., Tick L; MaximaMC Eindhoven, Eindhoven, Netherlands., Valk P; Hôpital Citadelle, Liège (B), Belgium., Vekemans MC; Hôpital St Luc, Bruxelles, Belgium., van der Velden WJFM; Radboudumc Nijmegen, Nijmegen, Netherlands., de Weerdt O; St Antonius Hospital, Nieuwegein, Netherlands., Pabst T; Department of Oncology, University Hospital, Inselspital and University of Bern, Bern, Switzerland., Manz M; University Hospital, Zurich, Switzerland., Löwenberg B; Hôpital Citadelle, Liège (B), Belgium.

Publikováno v: Leukemia [Leukemia] 2020 Jul; Vol. 34 (7), pp. 1751-1759. Date of Electronic Publication: 2020 Feb 04.

Invasive histiocytic sarcoma of the lumbar spine in a ferret (Mustela putorius furo).

Autor: Warschau M; Clinic for Pets, Reptiles and Pet and Feral Birds, University of Veterinary Medicine, D-30559, Hannover, Germany., Hoffmann M; Small Animal Clinic Neandertal, D-42781, Haan, Germany., Dziallas P; Small Animal Clinic, University of Veterinary Medicine, D-30559, Hannover, Germany., Hansmann F; Department of Pathology, University of Veterinary Medicine Hannover, D-30559, Hannover, Germany., Baumgärtner W; Department of Pathology, University of Veterinary Medicine Hannover, D-30559, Hannover, Germany., Mischke R; Small Animal Clinic, University of Veterinary Medicine, D-30559, Hannover, Germany., Cichowski S; Small Animal Practice, D-49201, Dissen, Germany., Fehr M; Small Animal Clinic, University of Veterinary Medicine, D-30559, Hannover, Germany.

Publikováno v: The Journal of small animal practice [J Small Anim Pract] 2017 Feb; Vol. 58 (2), pp. 115-118.

Assessment of wound bio-burden and prevalence of multi-drug resistant bacteria during open wound management.

Autor: Nolff MC; Clinic for Small Animal Surgery and Reproduction, Ludwig-Maximilians-University, Veterinärstrasse 13, Munich, 80539, Germany., Reese S; Department for Basic Veterinary Sciences, Ludwig-Maximilians-University, Professor-Huber-Platz 2, Munich, 80539, Germany., Fehr M; Small Animal Clinic, University of Veterinary Medicine of Hannover, Bünteweg 2, 30559, Hannover, Germany., Dening R; Small Animal Clinic, University of Veterinary Medicine of Hannover, Bünteweg 2, 30559, Hannover, Germany., Meyer-Lindenberg A; Clinic for Small Animal Surgery and Reproduction, Ludwig-Maximilians-University, Veterinärstrasse 13, Munich, 80539, Germany.

Publikováno v: The Journal of small animal practice [J Small Anim Pract] 2016 May; Vol. 57 (5), pp. 255-9. Date of Electronic Publication: 2016 Apr 21.